The Ups and Downs of Meds and Diabetes (Part 3): Blood Lipids

By Amy Campbell | June 30, 2008 4:52 pm

For the past two weeks, we’ve been delving into various medications that are often prescribed for people with diabetes (see "The Ups and Downs of Meds and Diabetes (Part 1): Steroids" and "The Ups and Downs of Meds and Diabetes (Part 2): Blood Pressure"). Some of these drugs, such as steroids, have a direct effect on blood glucose levels. All drugs have some side effects, so it’s important to have a clear understanding of what these are. Over these next two weeks, we’ll look at classes of drugs that are used to lower cholesterol and triglyceride levels.

Statins: One of the most effective and powerful classes of drugs that can lower LDL (or “bad”) cholesterol are the statins[1]. A major clinical trial has shown that statins can lower the risk of cardiovascular events in people with Type 2 diabetes by 37% and the risk of stroke[2] by 48%. Since we know that people with Type 2 diabetes are at high risk for heart disease, these are pretty significant findings. Some health-care providers believe that statins should be routinely prescribed for everyone who has Type 2 diabetes, regardless of their level of LDL cholesterol.

Advertisement

Statins work in the liver by blocking a substance that makes cholesterol. They can also help the body reabsorb cholesterol that’s been deposited along artery walls, lowering the risk of blockage. Common statins include atorvastatin (brand name Lipitor), simvastatin (Zocor), fluvastatin (Lescol), pravastatin (Pravachol), lovastatin (Mevacor), and rosuvastatin (Crestor). The statins all work pretty much the same way, although the doses for each can vary. Statins also come in combination with other meds: Advicor (lovastatin plus niacin, a B vitamin that helps raise HDL, or “good,” cholesterol and lower LDL cholesterol and triglycerides), Caduet (atorvastatin plus amlodipine, a calcium-channel blocker that treats high blood pressure), and Vytorin (simvastatin plus ezetimibe, a drug that blocks the absorption of cholesterol).

Despite often being touted as miracle drugs, statins do come with their fair share of side effects. In some people, statins can increase liver enzymes. Mild increases are usually not of much concern, but severe increases can lead to permanent liver damage. Liver function tests (LFTs) must therefore be taken regularly if you take a statin. Statins may also cause a condition called myopathy, which is muscle pain, and a more serious condition called rhabdomyolysis in which muscle tissue breaks down. This condition can lead to kidney damage, as well. Any muscle tenderness or soreness you experience while taking a statin should be reported immediately to your health-care provider.

Fortunately, both liver and muscle problems are relatively rare occurrences with statins. Also, statins may have benefits that extend beyond just lowering LDL cholesterol. Some early evidence points to statins being helpful for preventing arthritis, bone fractures, and even Alzheimer disease. Statins may also be considered for helping to treat metabolic syndrome[3].

Selective cholesterol absorption inhibitors: This is a fairly new class of meds that works in the intestine, rather than the liver, to block the absorption of cholesterol. Ezetimibe (Zetia) is the first drug in this class to be approved. Ezetimibe primarily works to lower LDL cholesterol, but may also lower triglycerides and raise HDL cholesterol slightly. This med is sometimes prescribed to people who can’t tolerate statins.

Ezetimibe also comes combined with simvastatin in a drug called Vytorin. Side effects can include headache, dizziness, diarrhea, joint pain, and, less commonly, hives, rash, and difficulty breathing. A major study, called the ENHANCE trial, looked at the effectiveness of the combo med, ezetimibe/simvastatin, in reducing plaque build-up in artery walls. While the researchers concluded that this combo drug was no more effective than simvasatin alone in reducing plaque build-up, the combo drug did help lower LDL levels. Also, the study wasn’t large or long enough to make any firm conclusions. (For more about this study, see “Vytorin Study Results Disappoint.”[4])

If you take ezetimibe or the combo version, it’s worthwhile to talk to your health-care provider about the ENHANCE trial and to make sure that this drug is the best choice for you.

I should also add that, no matter what lipid-lowering drug you may be taking, you still need to follow the lifestyle recommendations of eating a heart-healthy diet, getting regular physical activity[5], and stopping smoking[6].

More on lipid meds next week!

Endnotes:
  1. statins: http://www.diabetesselfmanagement.com/articles/Diabetes_Definitions/Statins
  2. stroke: http://www.diabetesselfmanagement.com/articles/Diabetes_Definitions/Stroke
  3. metabolic syndrome: http://www.diabetesselfmanagement.com/articles/Diabetes_Definitions/Syndrome_X
  4. “Vytorin Study Results Disappoint.”: http://www.diabetesselfmanagement.com/blog/Tara_Dairman/Vytorin_Study_Results_Disappoint
  5. physical activity: http://www.diabetesselfmanagement.com/articles/Exercise/Physical_Activity_The_Magic_of_Movement
  6. stopping smoking: http://www.diabetesselfmanagement.com/blog/Tara_Dairman/Quitting_Smoking_as_a_Group

Source URL: http://www.diabetesselfmanagement.com/blog/the-ups-and-downs-of-meds-and-diabetes-part-3-blood-lipids/


Amy Campbell: Amy Campbell is the author of Staying Healthy with Diabetes: Nutrition and Meal Planning and a frequent contributor to Diabetes Self-Management and Diabetes & You. She has co-authored several books, including the The Joslin Guide to Diabetes and the American Diabetes Association’s 16 Myths of a “Diabetic Diet,” for which she received a Will Solimene Award of Excellence in Medical Communication and a National Health Information Award in 2000. Amy also developed menus for Fit Not Fat at Forty Plus and co-authored Eat Carbs, Lose Weight with fitness expert Denise Austin.

Amy earned a bachelor’s degree in nutrition from Simmons College and a master’s degree in nutrition education from Boston University. In addition to being a Registered Dietitian, she is a Certified Diabetes Educator and a member of the American Dietetic Association, the American Diabetes Association, and the American Association of Diabetes Educators. Amy was formerly a Diabetes and Nutrition Educator at Joslin Diabetes Center, where she was responsible for the development, implementation, and evaluation of disease management programs, including clinical guideline and educational material development, and the development, testing, and implementation of disease management applications. She is currently the Director of Clinical Education Content Development and Training at Good Measures. Amy has developed and conducted training sessions for various disease and case management programs and is a frequent presenter at disease management events.

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.